1-2 of 2
Antonello Di Paolo, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Sara Galimberti, MD PhD, Cristina Bucelli, MD, Elena Arrigoni, PhD, Claudia Baratè, Susanna Grassi, Federica Ricci, MD, Francesca Guerrini, PhD, Elena Ciabatti, PhD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, MD, Giovanna Rege Cambrin, MD, Alessandro Isidori, MD PhD, Federica Loscocco, PhD, Giovanni Caocci, MD, Marianna Greco, PhD, Monica Bocchia, MD, Lara Aprile, MD, Antonella Gozzini, MD, Barbara Scappini, MD, Daniele Cattaneo, MD, Giorgio La Nasa, MD, Alberto Bosi, MD, Mario Petrini, MD PhD, Pietro Leoni, MD, Romano Danesi, MD PhD, Giuseppe Saglio, MD PhD, Giuseppe Visani, MD, Agostino Cortellezzi, MD, Anna Rita Scortechini, MD, Alessandra Iurlo, MD, Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3951.
https://doi.org/10.1182/blood.V128.22.3951.3951
Published: 2016
Journal Articles

Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib

Sara Galimberti, MD PhD, Laura Galeotti, PhD, Francesco Ceccherini, PhD, Marialuisa Polillo, Dr, Claudia Baratè, MD, Giulia Fontanelli, MD, Francesca Guerrini, PhD, Roberta Arici, ScD, Sara Barsotti, MD, Federica Ricci, Lara Aprile, MD, Fulvio Cornolti, Prof., Mario Petrini, MD, Monica Bocchia, MD PhD Prof., Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3608.
https://doi.org/10.1182/blood.V124.21.3608.3608
Published: 2014